COVID-19 vaccines likely to have longer shelf life

A longer shelf life is critical, given many makers have started manufacturing vaccines and stockpiling them, so as to make them available in the market immediately after approval,......

7 Indian pharma players race to develop COVID-19 vaccine

At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already......

Serum Institute ready to roll out Covid vaccine

With the government approving two COVID-19 vaccines for emergency use, Serum Institute on Sunday said it is ready to roll out Covishield vaccine in India in the coming weeks, while Bharat Biotech......

The people who make Modi look stylish

Modi's monogrammed suit on display at its auction in Surat. Photograph: Yaacov Saar/Reuters   The store that made Prime Minister Narendra Modi's monogrammed suit in Ahmedabad are now flooded......

Zydus Cadila, Mayne form JV

Pharma major Zydus Cadila on Thursday entered into an agreement with Mayne Pharma of Australia to set up a 50:50 joint venture company to manufacture generic injectible cytotoxic (anti-cancer)......

Zydus Cadila ties up with French firm

Zydus Cadila has tied up with France's second largest pharmacy network company Evolupharm to strengthen its presence in the euro1.5 billion French generics market. Evolupharm, which is the second......

Cadila gets USFDA nod for new diabetes molecule

Cadila Healthcare said on Thursday it has received approval from the US health regulator to carry out clinical trials of its new drug molecule, ZYGK1, aimed at treating diabetes.Approval was given......

Zydus debuts in Japan's generics mart

Zydus, one of the leading domestic integrated healthcare groups, is foraying into Japan's $3.5 billion generics market. The group already has operations in the US, Europe and Brazil.Headquartered......